Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo after First-Line Chemotherapy in Patients with Metastatic Urothelial Cancer

Matthew D. Galsky, Amir Mortazavi, Matthew I. Milowsky, Saby George, Sumati Gupta, Mark T. Fleming, Long H. Dang, Daniel M. Geynisman, Radhika Walling, Robert S. Alter, Mohamad Kassar, Jue Wang, Shilpa Gupta, Nancy Davis, Joel Picus, George Philips, David I. Quinn, G. Kenneth Haines, Noah M. Hahn, Qianqian ZhaoMenggang Yu, Sumanta K. Pal

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo after First-Line Chemotherapy in Patients with Metastatic Urothelial Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences